Fractyl Health, Inc. Common Stock
GUTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $17 | $21 | $19 | $20 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $5 | $5 | $5 |
| Operating Expenses | $22 | $26 | $25 | $25 |
| Operating Income | -$23 | -$26 | -$25 | -$25 |
| % Margin | – | – | – | -840,333.3% |
| Other Income/Exp. Net | -$23 | -$2 | $1 | $0 |
| Pre-Tax Income | -$46 | -$28 | -$24 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$46 | -$28 | -$24 | -$25 |
| % Margin | – | – | – | -832,333.3% |
| EPS | -0.71 | -0.57 | -0.49 | -0.51 |
| % Growth | -24.6% | -16.3% | 3.9% | – |
| EPS Diluted | -0.71 | -0.57 | -0.49 | -0.51 |
| Weighted Avg Shares Out | 65 | 49 | 49 | 49 |
| Weighted Avg Shares Out Dil | 65 | 49 | 49 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$45 | -$26 | -$24 | -$25 |
| % Margin | – | – | – | -832,900% |